Deal News
Pyxis Oncology signs agreement to buy Apexigen
Pyxis Oncology has made a definitive agreement to buy biopharmaceutical company Apexigen, in a deal valued at nearly $16m. Pyxis…
Avrobio to sell cystinosis gene therapy to Novartis for $87.5m
Avrobio has announced a deal to sell its investigational haematopoietic stem cell (HSC) gene therapy programme, designed to treat cystinosis,…
Ironwood Pharmaceuticals agrees to buy VectivBio for $1bn
Ironwood Pharmaceuticals has entered into a definitive agreement to buy Swiss biopharmaceutical company VectivBio in an all-cash deal valued at…
Alimera Sciences buys US rights to EyePoint’s Yutiq
Alimera Sciences has acquired the US commercialisation rights for Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg from EyePoint Pharmaceuticals. Yutiq is…
MIF invests in Nectin to investigate multiple myeloma drug candidate
Multiple Myeloma Research Foundation’s (MMRF) venture philanthropy subsidiary Myeloma Investment Fund (MIF) has made an undisclosed investment in Nectin Therapeutics…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Juno Pharmaceuticals buys Omega Laboratories
Juno Pharmaceuticals Canada has purchased Omega Laboratories, a specialist injectable pharmaceutical manufacturer in Canada, for an undisclosed sum. The merged…
NUCLIDIUM and PharmaLogic partner to develop copper-based theranostics in US
NUCLIDIUM has signed a strategic collaboration deal with PharmaLogic for the manufacturing and clinical supply of copper-based theranostics ⁶¹Cu in…
Private investment consortium to buy Syneos Health for $7.1bn
A consortium of private investment firm affiliates has signed a definitive deal to purchase biopharmaceutical solutions provider Syneos Health for…
Sobi agrees to buy CTI BioPharma for $1.7bn
Swedish Orphan Biovitrum (Sobi) has entered into a definitive agreement to buy biopharmaceutical company CTI BioPharma in an all-cash deal…
Alvotech and Polifarma sign agreement to commercialise AVT06 in Turkey
Alvotech has signed an exclusive agreement with Polifarma to commercialise AVT06, a planned biosimilar to Eylea (aflibercept), in Turkey. Alvotech…